Logan Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,400
Closed -$301K 293
2018
Q3
$301K Buy
6,400
+400
+7% +$18.8K 0.02% 263
2018
Q2
$296K Buy
+6,000
New +$296K 0.02% 260
2015
Q3
Sell
-10,000
Closed -$315K 295
2015
Q2
$315K Buy
10,000
+1,100
+12% +$34.7K 0.02% 266
2015
Q1
$261K Buy
+8,900
New +$261K 0.02% 258